Table 2.
Potential glucose thresholds for surveillance of type 1 diabetes diagnosis by negative predictive value at 6 months and number of 2-hour oral glucose tolerance tests that would need to be completed
OGTT glucose threshold, mg/dL | n | Sensitivity, % | Specificity, % | Negative predictive value at 6 mo, % | Participants requiring 2-h OGTT, % | |
---|---|---|---|---|---|---|
DPT-1 (n = 654) | 2-h ≥ 140 | 206 | 74.80 | 69.29 | 98.9 | 15.1 |
1-h ≥ 155 | 188 | 74.80 | 72.03 | 99.3 | 31.5 | |
1-h ≥ 160 | 130 | 41.40 | 80.55 | 99.3 | 28.7 | |
1-h ≥ 170 | 97 | 33.13 | 85.53 | 98.6 | 19.9 | |
1-h ≥ 180 | 63 | 24.86 | 90.84 | 98.5 | 14.8 | |
1-h ≥ 190 | 789 | 71.19 | 81.92 | 98.5 | 9.6 | |
TNPTP (n = 4610) | 2-h ≥ 140 | 1548 | 79.12 | 66.51 | 99.4 | 17.1 |
1-h ≥ 155 | 1338 | 75.85 | 70.96 | 99.5 | 33.6 | |
1-h ≥ 160 | 1011 | 74.21 | 78.36 | 99.4 | 29.0 | |
1-h ≥ 170 | 717 | 67.83 | 84.62 | 99.4 | 21.9 | |
1-h ≥ 180 | 500 | 52.15 | 89.52 | 99.4 | 15.6 | |
1-h ≥ 190 | 99 | 49.83 | 85.69 | 99.1 | 10.8 |
Abbreviations: DPT-1, Diabetes Prevention Trial–Type 1; OGTT, oral glucose tolerance test; TNPTP, TrialNet Pathway to Prevention.